BiotechMoney18's  Instablog

Send Message
Biotech & trend trader. Follow me twitter @BiotechMoney18 for more trade ideas.
  • 10 Reasons Why Idera Pharmaceutical, Inc (IDRA) Will Bring Significant Return To Your Portfolio In Months. 7 comments
    Sep 17, 2013 9:36 AM | about stocks: MRK, CUR, NBY, CYCC

    Yesterday my big winner bio pick was NBY, and month ago tweet out on CUR from 1.48 position which is doubled in price as of 9/16. Congrats again to those follow me on twitter and held. Follow me on twitter if you haven't already @BiotechMoney18 for more winner play.

    After CYCC successfully hit my target price on the last Instablog article. I decided to shares my next winner biotech pick that can bring significant return to your portfolio in coming months.

    Most SA articles go into much details on stocks they write, but I'm just going straight to 10 of my reasons why Idera Pharmaceutical (NASDAQ:IDRA) can make your portfolio look so GREEN with significant returned.

    Reasons to be Bullish:

    1. Insider buys, director bought 300,000 shares at $1.75 on 8/19 and yesterday, 9/16, 60,000 shares at 1.90 HE IS A BEAST! with the current price trading at closed on 9/16 at $1.62. This is a steal and we know when insider loaded up this much, this can only means up north in future.

    2. Baker Bro Advisor LP added 4,500,000 shares on the last update filing per NASDAQ most biotech traders/investors know Baker Bro had a very good successful rate in biotech world.

    3. Company recently files $75M mixed shelf. Which i think is good for long run and with cash equivalent of 16.3M this give them enough money to go through end of '14. No more dilution=very good.

    4. Entered agreements with NCI to evaluate the use of TLR Antagonist for treatment of genetically defined Lymphomas which will become very big down the road

    5. Collaboration with Merck (NYSE:MRK) TLR 7,8,9 agonists in field of oncology, infectious disease and Alzheimer's disease I smell buy out in future

    6. Their psoriasis patients treatment show a huge improvement. Check out their day 1 and day 29 result. This will become a little gems to shine

    7. IND for IMO-8400 in Q4 2013 and top line P2 IMO-8400 in Q1 2014. Huge catalyst play for filing in coming year end and beginning of next year result.

    8. U.S. patent covering IMO-8400 excellent

    9. Positive analyst from Piper Jaffray with $2.60 TP. and earning release was already out on 8/15 so there won't be any negative earning surprises or announcement

    10. No debt, decent institution support and insider ownership. Small float of 39.2M & the current market cap is only 73.19M this leave plenty of room to run. I also expect more analysts coverage & upgrades in future to go along with more institution filing increase on the next release.

    Target Price (TP) short term to mid-term $2.80-$3.2, Long Term $5+

    Reason to be bearish:


    Disclosure: I am long IDRA.

    Additional disclosure: I wrote this article myself and expresses my own opinions. Im not receiving any compensation for it. I have no affiliate with any of the company mentioned above. Im not adviser and suggest you do extra due diligence before taking position. Small cap bio tech always present with great risk and reward.

    Stocks: MRK, CUR, NBY, CYCC
Back To BiotechMoney18's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (7)
Track new comments
  • crt6978
    , contributor
    Comments (56) | Send Message
    THX,I will certainly read up more and put IDRA on my DD/buy now list.People like you who are willing to help everyone else are the salt of the Earth.
    17 Sep 2013, 10:19 AM Reply Like
  • ManiakTT
    , contributor
    Comments (93) | Send Message
    17 Sep 2013, 11:18 AM Reply Like
  • Thephoenix4
    , contributor
    Comments (5) | Send Message
    Nice blog on IDRA! Good work!
    17 Sep 2013, 10:36 PM Reply Like
  • 104192
    , contributor
    Comments (185) | Send Message
    Thanks for sharing your trading idea, I will follow. Long $IDRA!
    20 Sep 2013, 02:23 AM Reply Like
  • atrickpay
    , contributor
    Comments (504) | Send Message
    looks good to me except stock price is 9x (1.80 from 0.20) 52 week lows + and shelf was filed...i'm wondering if they will use it here..the form 4 buys in sept make it a bit less likely i think
    20 Sep 2013, 09:54 AM Reply Like
  • atrickpay
    , contributor
    Comments (504) | Send Message
    was 3.591$m net loss in q2, $3.807m net loss in q1. Current assets as of 6.30 16.958$m, 3.024$m in current liabilities (and $3.031m in net liabilities). Also there's warrants for 1m shares @ $0.61, issued april 22, 2013. Also issued on april 30, 2013, 1m warrants @$0.79


    20 Sep 2013, 10:13 AM Reply Like
  • askthepharmacist
    , contributor
    Comment (1) | Send Message
    Investing in the stock market today can be tricky because no one can really predict when it will surge or when it will fall. However, the pharmaceutical industry as a whole is a pretty solid and stable industry and I think investing on it might have some benefits in the long run.




    Ask The Pharmacist\
    13 Jul 2014, 11:46 PM Reply Like
Full index of posts »
Latest Followers


More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.